Tenaya Therapeutics (TNYA) Retained Earnings (2020 - 2026)

Tenaya Therapeutics' Retained Earnings history runs 7 years deep, the most recent figure standing at -$624.3 million for Q1 2026.

• In Q1 2026, Retained Earnings fell 6242900.0% year-over-year to -$624.3 million; the TTM figure through Mar 2026 stood at -$624.3 million (down 6242900.0% YoY), while the FY2025 annual figure was -$605.0 million, down 17.61% from the prior year.
• Retained Earnings was -$624.3 million for Q1 2026 at Tenaya Therapeutics, down from -$605.0 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$10000.0 in Q1 2025 to a low of -$624.3 million in Q1 2026.
• Historically, Retained Earnings has averaged -$341.3 million across 5 years, with a median of -$403.3 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Retained Earnings jumped 100.0% in 2025, then tumbled 6242900.0% in 2026.
• A 5-year view of Retained Earnings shows it stood at -$279.2 million in 2022, then slumped by 44.44% to -$403.3 million in 2023, then fell by 27.56% to -$514.4 million in 2024, then retreated by 17.61% to -$605.0 million in 2025, then declined by 3.19% to -$624.3 million in 2026.
• The last three Retained Earnings figures came in at -$624.3 million (Q1 2026), -$605.0 million (Q4 2025), and -$584.8 million (Q3 2025), per Business Quant data.